Gainers
- 4D Molecular Therapeutics (NASDAQ:FDMT) shares moved upwards by 24.5% to $9.59 during Thursday's regular session. Trading volume for this security as of 13:30 EST is 994.4K, which is 361.2% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $310.5 million.
- Acorda Therapeutics (NASDAQ:ACOR) stock increased by 23.78% to $0.6. As of 13:30 EST, Acorda Therapeutics's stock is trading at a volume of 12.0 million, which is 424.8% of its average full-day volume over the last 100 days. The company's market cap stands at $14.6 million.
- Community Health Systems (NYSE:CYH) shares rose 21.7% to $2.8. Community Health Systems's stock is trading at a volume of 5.5 million shares as of 13:30 EST. This is 184.7% of its average full-day volume over the last 100 days. The company's market cap stands at $377.0 million. The company's, Q3 earnings came out yesterday.
- Surface Oncology (NASDAQ:SURF) stock increased by 15.92% to $1.31. Trading volume for this security as of 13:30 EST is 880.3K, which is 181.1% of its average full-day volume over the last 100 days. The company's market cap stands at $76.0 million.
- NeuroBo Pharmaceuticals (NASDAQ:NRBO) stock rose 12.82% to $9.15. As of 13:30 EST, NeuroBo Pharmaceuticals's stock is trading at a volume of 2.1 million, which is 399.7% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $8.1 million.
- Eton Pharmaceuticals (NASDAQ:ETON) shares rose 12.78% to $2.65. Eton Pharmaceuticals's stock is trading at a volume of 181.6K shares as of 13:30 EST. This is 263.7% of its average full-day volume over the last 100 days. The company's market cap stands at $67.0 million.
Losers
- TransCode Therapeutics (NASDAQ:RNAZ) shares declined by 20.9% to $0.91 during Thursday's regular session. The current volume of 1.9 million shares is 367.8% of TransCode Therapeutics's average full-day volume over the last 100 days (last updated at 13:30 EST). The market value of their outstanding shares is at $11.8 million.
- Taysha Gene Therapies (NASDAQ:TSHA) shares decreased by 19.45% to $1.74. The current volume of 10.9 million shares is 665.8% of Taysha Gene Therapies's average full-day volume over the last 100 days (last updated at 13:30 EST). The market value of their outstanding shares is at $71.5 million.
- Y-mAbs Therapeutics (NASDAQ:YMAB) stock decreased by 19.03% to $8.91. Trading volume for this security as of 13:30 EST is 1.1 million, which is 387.6% of its average full-day volume over the last 100 days. The company's market cap stands at $389.7 million.
- Align Tech (NASDAQ:ALGN) shares decreased by 17.51% to $182.84. Trading volume for Align Tech's stock is 2.3 million as of 13:30 EST. This is 273.1% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $14.2 billion. As per the press release, Q3 earnings came out yesterday.
- Tricida (NASDAQ:TCDA) shares declined by 16.3% to $0.39. Trading volume for Tricida's stock is 17.5 million as of 13:30 EST. This is 526.6% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $21.7 million.
- ENDRA Life Sciences (NASDAQ:NDRA) stock fell 14.28% to $0.27. As of 13:30 EST, ENDRA Life Sciences's stock is trading at a volume of 658.7K, which is 204.0% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $17.3 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
